Holen Sie sich die Stockscreener-App
4.01
2.04%
0.08
Handel nachbörslich:
4.02
0.010
+0.25%
Schlusskurs vom Vortag:
$3.93
Offen:
$3.95
24-Stunden-Volumen:
1.04M
Relative Volume:
1.31
Marktkapitalisierung:
$768.71M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-74.39M
KGV:
-9.1136
EPS:
-0.44
Netto-Cashflow:
$-78.92M
1W Leistung:
+9.26%
1M Leistung:
+20.06%
6M Leistung:
+18.29%
1J Leistung:
-1.96%
1-Tages-Spanne:
$3.88
$4.03
1-Wochen-Bereich:
$3.65
$4.095
52-Wochen-Spanne:
$2.705
$4.725
Arbutus Biopharma Corp Stock (ABUS) Company Profile
Firmenname
Arbutus Biopharma Corp
Sektor
Branche
Telefon
604-419-3200
Adresse
701 VETERANS CIRCLE, WARMINSTER, PA
Vergleichen Sie ABUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.01 | 732.29M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-02-02 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-25 | Eingeleitet | Jefferies | Hold |
| 2020-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-27 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2020-07-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | Hochstufung | Wedbush | Neutral → Outperform |
| 2020-03-06 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-05 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | Bestätigt | B. Riley FBR | Buy |
| 2019-10-04 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | Hochstufung | Wedbush | Underperform → Neutral |
| 2018-10-12 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-07-06 | Herabstufung | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2018-03-19 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | Bestätigt | Wedbush | Outperform |
| 2016-12-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
Alle ansehen
Arbutus Biopharma Corp Aktie (ABUS) Neueste Nachrichten
Should value investors consider Arbutus Biopharma CorporationEarnings Risk Report & Expert Verified Stock Movement Alerts - khodrobank.com
Analyzing recovery setups for Arbutus Biopharma Corporation investorsRate Cut & Free Weekly Watchlist of Top Performers - Newser
Is Arbutus Biopharma Corporation vulnerable to short sellersMarket Movement Recap & Daily Profit Maximizing Tips - khodrobank.com
Using flow based indicators on Arbutus Biopharma CorporationJuly 2025 Levels & Verified Chart Pattern Signals - Newser
Using data models to predict Arbutus Biopharma Corporation stock movementMarket Performance Summary & Daily Entry Point Alerts - Newser
Published on: 2025-09-03 05:15:59 - Newser
Chart based analysis of Arbutus Biopharma Corporation trendsOptions Play & Low Drawdown Investment Ideas - Newser
Tools to monitor Arbutus Biopharma Corporation recovery probability2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
What MACD and RSI say about Arbutus Biopharma CorporationMarket Performance Summary & Advanced Technical Analysis Signals - Newser
Can Arbutus Biopharma Corporation sustain earnings growth2025 Growth vs Value & Trade Opportunity Analysis - khodrobank.com
Arbutus Biopharma Corporation’s volatility index tracking explained2025 Performance Recap & Risk Managed Trade Strategies - Newser
Custom watchlist performance reports with Arbutus Biopharma CorporationWeekly Trend Recap & Stock Portfolio Risk Control - Newser
Volume spikes in Arbutus Biopharma Corporation stock – what they meanPortfolio Value Summary & High Conviction Investment Ideas - Newser
Is Arbutus Biopharma Corporation trending in predictive chart modelsJuly 2025 Summary & Daily Stock Trend Reports - Newser
Arbutus Biopharma Corporation stock daily chart insights2025 Market Trends & Low Risk High Win Rate Stock Picks - Newser
Nuveen LLC Invests $1.09 Million in Arbutus Biopharma Corporation $ABUS - Defense World
How to read the order book for Arbutus Biopharma CorporationJuly 2025 Setups & AI Forecast Swing Trade Picks - Newser
Is Arbutus Biopharma Corporation undervalued by DCF analysisMarket Growth Report & Reliable Price Breakout Signals - khodrobank.com
How to build a custom watchlist for Arbutus Biopharma CorporationJuly 2025 Review & Free Technical Pattern Based Buy Signals - Newser
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year? - ca.finance.yahoo.com
Is Arbutus Biopharma Corporation on track to beat earningsJuly 2025 Technicals & Fast Entry and Exit Trade Plans - khodrobank.com
Can swing trading help recover from Arbutus Biopharma Corporation lossesMarket Volume Summary & Safe Capital Growth Trade Ideas - Newser
Technical analysis overview for Arbutus Biopharma Corporation stock - Newser
Measuring Arbutus Biopharma Corporation’s beta against major indicesPrice Action & Weekly Market Pulse Alerts - Newser
Published on: 2025-08-30 22:10:35 - Newser
Applying sector rotation models to Arbutus Biopharma CorporationWeekly Trend Recap & Technical Confirmation Alerts - Newser
Developing predictive dashboards with Arbutus Biopharma Corporation dataMarket Sentiment Summary & Accurate Buy Signal Alerts - Newser
Real time scanner hits for Arbutus Biopharma Corporation explainedJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Technical signs of recovery in Arbutus Biopharma Corporation2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
Arbutus Biopharma Corporation stock outlook for YEARMarket Rally & Weekly Stock Performance Updates - Newser
Key metrics from Arbutus Biopharma Corporation’s quarterly data2025 Fundamental Recap & Low Risk Growth Stock Ideas - Newser
Finanzdaten der Arbutus Biopharma Corp-Aktie (ABUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):